{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:26:58Z","timestamp":1782386818217,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["40000455"],"award-info":[{"award-number":["40000455"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.talanta.2021.122163","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T18:10:32Z","timestamp":1612289432000},"page":"122163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Capillary electrophoresis as a fragment screening tool to cross-validate hits from chromogenic assay: Application to FXIIa"],"prefix":"10.1016","volume":"226","author":[{"given":"C.","family":"Davoine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2021.122163_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cellsig.2018.08.006","article-title":"Factor XII in coagulation, inflammation and beyond","volume":"51","author":"Didiasova","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.talanta.2021.122163_bib2","first-page":"1","article-title":"Coagulation pathways in neurological diseases: multiple sclerosis, front","volume":"10","author":"Ziliotto","year":"2019","journal-title":"Neurol."},{"key":"10.1016\/j.talanta.2021.122163_bib4","author":"Treatment With CSL312 in Adults With Coronavirus Disease 2019"},{"key":"10.1016\/j.talanta.2021.122163_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/CIRCRESAHA.118.313155","article-title":"Antithrombotic agents","volume":"124","author":"Chan","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.talanta.2021.122163_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0037-1603937","article-title":"Inhibition of factors XI and XII for prevention of thrombosis induced by artificial surfaces","volume":"44","author":"Tillman","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.talanta.2021.122163_bib8","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI77139","article-title":"Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III","volume":"125","author":"Bj\u00f6rkqvist","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.talanta.2021.122163_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13984-8","article-title":"Cold-induced urticarial autoinflammatory syndrome related to factor XII activation","volume":"11","author":"Scheffel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.talanta.2021.122163_bib10","first-page":"599","article-title":"Factor XII - what's important but not commonly thought about, Res. Pract. Thromb","volume":"3","author":"Schmaier","year":"2019","journal-title":"Haemostasis"},{"key":"10.1016\/j.talanta.2021.122163_bib11","first-page":"2118","article-title":"The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity, Biochim. Biophys","volume":"1864","author":"Weidmann","year":"2017","journal-title":"Acta - Mol. Cell Res."},{"key":"10.1016\/j.talanta.2021.122163_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.116.308595","article-title":"Factor XII as a therapeutic target in thromboembolic and inflammatory diseases","volume":"37","author":"Nickel","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.talanta.2021.122163_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00791","article-title":"Role of coagulation pathways in neurological diseases","volume":"10","author":"Lorenzano","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.talanta.2021.122163_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.blre.2018.04.001","article-title":"Plasma contact factors as therapeutic targets","volume":"32","author":"Tillman","year":"2018","journal-title":"Blood Rev."},{"key":"10.1016\/j.talanta.2021.122163_bib15","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1021\/jm8002697","article-title":"Novel 3-Carboxamide-coumarins as potent and selective FXIIa inhibitors","volume":"51","author":"Robert","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejmech.2016.01.023","article-title":"Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors","volume":"110","author":"Bouckaert","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.thromres.2017.07.015","article-title":"Discovery and assessment of water soluble coumarins as inhibitors of the coagulation contact pathway","volume":"157","author":"Bouckaert","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.talanta.2021.122163_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2017.08.056","article-title":"Identifying novel factor XIIa inhibitors with PCA-GA-SVM developed vHTS models","volume":"140","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib19","series-title":"FACTOR XIIa INHIBITORS, WO\/2019\/211585","author":"Philippou","year":"2019"},{"key":"10.1016\/j.talanta.2021.122163_bib20","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b01581","article-title":"Fragment-to-Lead medicinal chemistry publications in 2018","author":"Erlanson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/EBC20170028","article-title":"Current perspectives in fragment-based lead discovery (FBLD)","volume":"61","author":"Lamoree","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.talanta.2021.122163_bib22","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1021\/acs.jmedchem.6b00197","article-title":"Design principles for fragment libraries: maximizing the value of learnings from pharma fragment-based drug discovery (FBDD) programs for use in academia","volume":"59","author":"Keseru","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib23","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.bmcl.2013.03.028","article-title":"Learning from our mistakes\u00a0: the \u2018 unknown knowns \u2019 in fragment screening, Bioorg","volume":"23","author":"Davis","year":"2013","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.talanta.2021.122163_bib24","first-page":"1","article-title":"Biophysics in drug discovery: impact, challenges and opportunities","author":"Renaud","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.talanta.2021.122163_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymeth.2018.05.006","article-title":"Affinity capillary electrophoresis for studying interactions in life sciences","volume":"146","author":"Olabi","year":"2018","journal-title":"Methods"},{"key":"10.1016\/j.talanta.2021.122163_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpba.2017.02.022","article-title":"Capillary electrophoresis in the context of drug discovery","volume":"144","author":"Farcas","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2021.122163_bib27","first-page":"211","article-title":"Partial filling affinity capillary electrophoresis as a useful tool for fragment-based drug discovery: a proof of concept on thrombin, Anal. Chim","volume":"984","author":"Farca\u015f","year":"2017","journal-title":"Acta"},{"key":"10.1016\/j.talanta.2021.122163_bib28","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1007\/s00216-018-1107-6","article-title":"Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1","volume":"410","author":"Neaga","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib29","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1021\/acs.analchem.6b01430","article-title":"Screening of small-molecule inhibitors of protein-protein interaction with capillary electrophoresis frontal analysis","volume":"88","author":"Xu","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/1087057112445785","article-title":"Fragment screening using capillary electrophoresis (CEfrag) for hit identification of heat shock protein 90 ATPase inhibitors","volume":"17","author":"Austin","year":"2012","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.talanta.2021.122163_bib31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/elps.201600367","article-title":"Screening of tyrosinase inhibitors by capillary electrophoresis with immobilized enzyme microreactor and molecular docking","volume":"38","author":"Cheng","year":"2017","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib32","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1002\/elps.200900073","article-title":"Affinity in electrophoresis","volume":"30","author":"Heegaard","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib33","first-page":"367","article-title":"Aflinity capillary electrophoresis","author":"Colton","year":"1998","journal-title":"A physical-organic tool for studying interactions in biomolecular recognition"},{"key":"10.1016\/j.talanta.2021.122163_bib34","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/elps.201700385","article-title":"Into the theory of the partial-filling affinity capillary electrophoresis and the determination of apparent stability constants of analyte-ligand complexes","volume":"39","author":"Ansorge","year":"2018","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/bloodadvances.2018016337","article-title":"Structures of human plasma \u03b2-factor XIIa cocrystallized with potent inhibitors","volume":"2","author":"Dementiev","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.talanta.2021.122163_bib36","series-title":"Second Edi","article-title":"Evaluation of enzyme inhibitors in drug discovery\u00a0: a guide for medicinal chemists and pharmacologists","author":"Copeland","year":"2013"},{"key":"10.1016\/j.talanta.2021.122163_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/abio.1996.0238","article-title":"Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase","volume":"237","author":"Kuzmi\u010d","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2021.122163_bib38","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/elps.200700108","article-title":"Reproducible protein analysis by CE using linear polyacrylamide-coated capillaries and hydrochloric acid rinsing","volume":"28","author":"Suratman","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/elps.200405918","article-title":"Determination of protein-ligand affinity constants from direct migration time in capillary electrophoresis","volume":"25","author":"Nilsson","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chroma.2016.04.004","article-title":"CEval: all-in-one software for data processing and statistical evaluations in affinity capillary electrophoresis","volume":"1445","author":"Dubsk\u00fd","year":"2016","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.talanta.2021.122163_bib41","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1432-1033.1987.tb11174.x","article-title":"Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa","volume":"164","author":"Tans","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.talanta.2021.122163_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0049-3848(00)00206-1","article-title":"The kinetic and structural characterization of the reaction of nafamostat with bovine pancreatic trypsin,","volume":"98","author":"Ramjee","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.talanta.2021.122163_bib43","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acschembio.5b00103","article-title":"A synthetic factor XIIa inhibitor blocks selectively intrinsic coagulation initiation,","volume":"10","author":"Baeriswyl","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.talanta.2021.122163_bib44","article-title":"Factor XII\/XIIa inhibitors: their discovery, development, and potential indications, Eur. J. Med. Chem","volume":"112753","author":"Davoine","year":"2020","journal-title":"208"},{"key":"10.1016\/j.talanta.2021.122163_bib45","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/elps.200900015","article-title":"Protein attachment onto silica surfaces - a survey of molecular fundamentals, resulting effects and novel preventive strategies in CE","volume":"30","author":"Stutz","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/jth.12849","article-title":"Coagulation factor XII protease domain crystal structure","volume":"13","author":"Pathak","year":"2015","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.talanta.2021.122163_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0378-4347(94)00440-G","article-title":"Sodium dodecyl sulfate solution is an effective between-run rinse for capillary electrophoresis of samples in biological matrices","volume":"663","author":"Lloyd","year":"1995","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.talanta.2021.122163_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cis.2010.12.007","article-title":"Understanding protein adsorption phenomena at solid surfaces","volume":"162","author":"Rabe","year":"2011","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.talanta.2021.122163_bib49","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1039\/c4tb00253a","article-title":"Binding characteristics between polyethylene glycol (PEG) and proteins in aqueous solution","volume":"2","author":"Wu","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.talanta.2021.122163_bib50","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1002\/elps.200405982","article-title":"Eigenmobilities in background electrolytes for capillary zone electrophoresis: IV. Computer program PeakMaster","volume":"25","author":"Jaro\u0161","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib51","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1002\/elps.200500029","article-title":"Peak shape modeling by Haarhoff-Van der Linde function for the determination of correct migration times: a new insight into affinity capillary electrophoresis","volume":"26","author":"Le Saux","year":"2005","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.chroma.2012.06.053","article-title":"A nonlinear electrophoretic model for PeakMaster: Part IV. Electromigration dispersion in systems that contain a neutral complex-forming agent and a fully charged analyte. Experimental verification","volume":"1267","author":"Bene\u0161","year":"2012","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.talanta.2021.122163_bib53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chroma.2012.06.086","article-title":"A nonlinear electrophoretic model for PeakMaster: Part III. Electromigration dispersion in systems that contain a neutral complex-forming agent and a fully charged analyte. Theory","volume":"1267","author":"Hru\u0161ka","year":"2012","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.talanta.2021.122163_bib54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/elps.201400463","article-title":"Determination of the correct migration time and other parameters of the Haarhoff-van der Linde function from the peak geometry characteristics","volume":"36","author":"Dubsk\u00fd","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2021.122163_bib55","series-title":"Enzyme kinetics: principles and methods","author":"Bisswanger","year":"2008"},{"key":"10.1016\/j.talanta.2021.122163_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/ml3003296","article-title":"Metal impurities cause false positives in high-throughput screening campaigns","volume":"4","author":"Hermann","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.talanta.2021.122163_bib57","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1016\/S0021-9258(18)31412-1","article-title":"Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement","volume":"268","author":"Bernardo","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.talanta.2021.122163_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm901070c","article-title":"Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease","volume":"53","author":"Jadhav","year":"2010","journal-title":"J. Med. Chem."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914021000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914021000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:03:53Z","timestamp":1777449833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914021000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":56,"alternative-id":["S0039914021000849"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2021.122163","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capillary electrophoresis as a fragment screening tool to cross-validate hits from chromogenic assay: Application to FXIIa","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2021.122163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122163"}}